• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺通过 LSD1 介导的 DNMT1 蛋白稳定化扰乱 Jurkat-T 细胞中的胞嘧啶甲基化。

Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein.

机构信息

Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an 710062, P. R. China.

出版信息

Chem Res Toxicol. 2011 Nov 21;24(11):2040-3. doi: 10.1021/tx2003849. Epub 2011 Nov 1.

DOI:10.1021/tx2003849
PMID:22007908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3221796/
Abstract

Aberrant cytosine methylation is known to be associated with cancer development. Here, we assessed how common cancer chemotherapeutic agents perturb cytosine methylation in Jurkat-T acute lymphoblastic leukemia cells. We tested six antitumor agents and found that cyclophosphamide induced the most pronounced increase in global DNA cytosine methylation after a 24-h treatment. Long-term treatment with cyclophosphamide led to a time-dependent increase in cytosine methylation level with up to 4 days of treatment, and the extent of cytosine methylation returned to normal level after 8 days. The trend of change in DNA methylation level paralleled that of the expression level of DNMT1 protein, whereas no significant increase in DNMT1 mRNA level was observed. Previous studies showed that the stability of endogenous DNMT1 protein is regulated by lysine methylation through histone lysine methyltransferase Set7 and lysine-specific demethylase 1 (LSD1), with the methylated DNMT1 being the target for proteasomal degradation. We observed that the elevated expression of DNMT1 protein at 4 days of treatment was correlated with the increased expression of LSD1 protein and with the decreased frequency of K142 methylation in DNMT1. Taken together, our results showed that cyclophosphamide perturbed temporarily global cytosine methylation in Jurkat-T cells via regulation of the lysine methylation level in DNMT1.

摘要

异常的胞嘧啶甲基化与癌症的发展有关。在这里,我们评估了常见的癌症化疗药物如何扰乱 Jurkat-T 急性淋巴细胞白血病细胞中的胞嘧啶甲基化。我们测试了六种抗肿瘤药物,发现环磷酰胺在 24 小时处理后诱导了最显著的全基因组 DNA 胞嘧啶甲基化增加。环磷酰胺的长期治疗导致胞嘧啶甲基化水平随时间呈依赖性增加,最长可达 4 天的治疗,并且在 8 天后胞嘧啶甲基化水平恢复正常。DNA 甲基化水平的变化趋势与 DNMT1 蛋白的表达水平平行,而 DNMT1 mRNA 水平没有明显增加。先前的研究表明,内源性 DNMT1 蛋白的稳定性通过组蛋白赖氨酸甲基转移酶 Set7 和赖氨酸特异性去甲基酶 1(LSD1)调控的赖氨酸甲基化来调节,其中甲基化的 DNMT1 是蛋白酶体降解的靶标。我们观察到,在 4 天的治疗中,DNMT1 蛋白表达的升高与 LSD1 蛋白表达的增加以及 DNMT1 中 K142 甲基化频率的降低相关。综上所述,我们的结果表明,环磷酰胺通过调节 DNMT1 中的赖氨酸甲基化水平暂时扰乱了 Jurkat-T 细胞中的全基因组胞嘧啶甲基化。

相似文献

1
Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein.环磷酰胺通过 LSD1 介导的 DNMT1 蛋白稳定化扰乱 Jurkat-T 细胞中的胞嘧啶甲基化。
Chem Res Toxicol. 2011 Nov 21;24(11):2040-3. doi: 10.1021/tx2003849. Epub 2011 Nov 1.
2
Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.LSD1(赖氨酸特异性去甲基化酶 1)的缺失以 p53 和 DNMT1(DNA 甲基转移酶 1)非依赖的方式抑制人结肠癌细胞的生长并改变其基因表达。
Biochem J. 2013 Jan 15;449(2):459-68. doi: 10.1042/BJ20121360.
3
6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1.6-硫鸟嘌呤通过促进蛋白酶体介导的 DNMT1 降解,使急性淋巴细胞白血病细胞中的表观遗传沉默基因重新激活。
Cancer Res. 2011 Mar 1;71(5):1904-11. doi: 10.1158/0008-5472.CAN-10-3430. Epub 2011 Jan 14.
4
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.赖氨酸去甲基化酶LSD1(KDM1)是维持全基因组DNA甲基化所必需的。
Nat Genet. 2009 Jan;41(1):125-9. doi: 10.1038/ng.268. Epub 2008 Dec 21.
5
Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells.通过SET7介导的赖氨酸甲基化调控哺乳动物细胞中DNMT1的稳定性
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5076-81. doi: 10.1073/pnas.0810362106. Epub 2009 Mar 12.
6
The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent.癌细胞中赖氨酸去甲基化酶KDM1A与DNA甲基转移酶之间的相互作用是细胞周期依赖性的。
Oncotarget. 2016 Sep 13;7(37):58939-58952. doi: 10.18632/oncotarget.10624.
7
Methyllysine reader plant homeodomain (PHD) finger protein 20-like 1 (PHF20L1) antagonizes DNA (cytosine-5) methyltransferase 1 (DNMT1) proteasomal degradation.甲基赖氨酸读蛋白植物同源结构域(PHD)手指蛋白 20 样 1(PHF20L1)拮抗 DNA(胞嘧啶-5)甲基转移酶 1(DNMT1)蛋白酶体降解。
J Biol Chem. 2014 Mar 21;289(12):8277-87. doi: 10.1074/jbc.M113.525279. Epub 2014 Feb 3.
8
6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo.6-硫鸟嘌呤在体外可通过DNA甲基转移酶干扰CpG二核苷酸位点的胞嘧啶甲基化,并在体内作为一种DNA去甲基化剂发挥作用。
Biochemistry. 2009 Mar 17;48(10):2290-9. doi: 10.1021/bi801467z.
9
SET8 prevents excessive DNA methylation by methylation-mediated degradation of UHRF1 and DNMT1.SET8 通过甲基化介导的 UHRF1 和 DNMT1 降解来防止过度的 DNA 甲基化。
Nucleic Acids Res. 2019 Sep 26;47(17):9053-9068. doi: 10.1093/nar/gkz626.
10
SET7/9 mediated methylation of non-histone proteins in mammalian cells.SET7/9 在哺乳动物细胞中介导非组蛋白的甲基化。
Epigenetics. 2009 Aug 16;4(6):383-7. doi: 10.4161/epi.4.6.9450. Epub 2009 Aug 6.

引用本文的文献

1
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer.RXRγ的相分离驱动肿瘤化疗耐药,并代表小细胞肺癌的一个治疗靶点。
Proc Natl Acad Sci U S A. 2025 May 27;122(21):e2421199122. doi: 10.1073/pnas.2421199122. Epub 2025 May 20.
2
Biological roles of LSD1 beyond its demethylase activity.LSD1 的去甲基化酶活性之外的生物学作用。
Cell Mol Life Sci. 2020 Sep;77(17):3341-3350. doi: 10.1007/s00018-020-03489-9. Epub 2020 Mar 19.
3
Towards Precision Medicine in Systemic Lupus Erythematosus.

本文引用的文献

1
6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1.6-硫鸟嘌呤通过促进蛋白酶体介导的 DNMT1 降解,使急性淋巴细胞白血病细胞中的表观遗传沉默基因重新激活。
Cancer Res. 2011 Mar 1;71(5):1904-11. doi: 10.1158/0008-5472.CAN-10-3430. Epub 2011 Jan 14.
2
Epigenetics in cancer.癌症中的表观遗传学。
Carcinogenesis. 2010 Jan;31(1):27-36. doi: 10.1093/carcin/bgp220. Epub 2009 Sep 13.
3
Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells.
迈向系统性红斑狼疮的精准医学
Pharmgenomics Pers Med. 2020 Feb 4;13:39-49. doi: 10.2147/PGPM.S205079. eCollection 2020.
4
DNA methylation changes on immune cells in Systemic Lupus Erythematosus.系统性红斑狼疮患者免疫细胞中的 DNA 甲基化改变。
Autoimmunity. 2020 May;53(3):114-121. doi: 10.1080/08916934.2020.1722108. Epub 2020 Feb 4.
5
Epigenetic Modifications in T Cells: The Role of DNA Methylation in Salt-Sensitive Hypertension.T 细胞中的表观遗传修饰:DNA 甲基化在盐敏感性高血压中的作用。
Hypertension. 2020 Feb;75(2):372-382. doi: 10.1161/HYPERTENSIONAHA.119.13716. Epub 2019 Dec 16.
6
Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer.精氨酸甲基化依赖性 LSD1 稳定性促进乳腺癌的侵袭和转移。
EMBO Rep. 2020 Feb 5;21(2):e48597. doi: 10.15252/embr.201948597. Epub 2019 Dec 12.
7
Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer.赖氨酸去甲基化酶KDM2A抑制TET2以促进乳腺癌中抑癌基因的DNA甲基化和沉默。
Oncogenesis. 2017 Aug 7;6(8):e369. doi: 10.1038/oncsis.2017.71.
8
Epigenetics in SLE.系统性红斑狼疮的表观遗传学。
Curr Rheumatol Rep. 2017 Sep;19(9):58. doi: 10.1007/s11926-017-0685-1.
9
Semi-quantitative proteomics of mammalian cells upon short-term exposure to non-ionizing electromagnetic fields.哺乳动物细胞短期暴露于非电离电磁场后的半定量蛋白质组学
PLoS One. 2017 Feb 24;12(2):e0170762. doi: 10.1371/journal.pone.0170762. eCollection 2017.
10
DNA methylation in systemic lupus erythematosus.系统性红斑狼疮中的DNA甲基化
Epigenomics. 2017 Apr;9(4):505-525. doi: 10.2217/epi-2016-0096. Epub 2016 Nov 25.
通过SET7介导的赖氨酸甲基化调控哺乳动物细胞中DNMT1的稳定性
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5076-81. doi: 10.1073/pnas.0810362106. Epub 2009 Mar 12.
4
6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo.6-硫鸟嘌呤在体外可通过DNA甲基转移酶干扰CpG二核苷酸位点的胞嘧啶甲基化,并在体内作为一种DNA去甲基化剂发挥作用。
Biochemistry. 2009 Mar 17;48(10):2290-9. doi: 10.1021/bi801467z.
5
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.赖氨酸去甲基化酶LSD1(KDM1)是维持全基因组DNA甲基化所必需的。
Nat Genet. 2009 Jan;41(1):125-9. doi: 10.1038/ng.268. Epub 2008 Dec 21.
6
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.地西他滨可改善骨髓增生异常综合征患者的预后:一项III期随机研究的结果
Cancer. 2006 Apr 15;106(8):1794-803. doi: 10.1002/cncr.21792.
7
Targeting multidrug resistance in cancer.针对癌症中的多药耐药性
Nat Rev Drug Discov. 2006 Mar;5(3):219-34. doi: 10.1038/nrd1984.
8
Eukaryotic cytosine methyltransferases.真核生物胞嘧啶甲基转移酶。
Annu Rev Biochem. 2005;74:481-514. doi: 10.1146/annurev.biochem.74.010904.153721.
9
Gene silencing in cancer in association with promoter hypermethylation.癌症中的基因沉默与启动子高甲基化相关。
N Engl J Med. 2003 Nov 20;349(21):2042-54. doi: 10.1056/NEJMra023075.
10
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.阿扎胞苷治疗骨髓增生异常综合征患者的随机对照试验:癌症与白血病B组研究
J Clin Oncol. 2002 May 15;20(10):2429-40. doi: 10.1200/JCO.2002.04.117.